Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease

Clinical Orthopaedics and Related Research

Volumn 352, Issue , 1998, Pages 159-167

  Glueck, C J ^a   Freiberg, R A ^a   Crawford, A ^b   Gruppo, R ^b   Roy, D ^b   Tracy, T ^a   Sieve Smith, L ^a   Wang, P ^a  

^a JEWISH HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; ENVIRONMENTAL EXPOSURE; HUMAN; MAJOR CLINICAL STUDY; PASSIVE SMOKING; PERTHES DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

EID: 0031841753     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199807000-00019     Document Type: Article

References (25)

1. Choi D, Lee DY, Chung CY, Rhyu KH, Park SY: Changes in coagulation-fibrinolysis system in Legg-Perthes disease: A preliminary report. Orthop Trans 2:1, 1995. Abstract.
2. Eriksen W, Bruusgaard D: Smoking behaviour in young families. Do parents take practical measures to prevent passive smoking by the children? Scand J Prim Health Care 13:275-280, 1995.
3. Glueck CJ, Brandt G, Gruppo R, et al: Resistance to activated protein C and Legg-Perthes disease. Clin Orthop 338:139-152, 1997.
4. Glueck CJ, Crawford A, Roy D, et al: Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg Perthes disease. J Bone Joint Surg 78A:3-13, 1996.
5. Glueck CJ, Freiberg R, Glueck HI, et al: Hypofibrinolysis: A common, major cause of osteonecrosis. Am J Hematol 45:156-166, 1994.
6. Glueck CJ, Freiberg R, Glueck HI, et al: Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high Lp(a), and therapy with Stanozolol. Am J Hematol 48:213-220, 1995.
7. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P: Thrombophilia and hypofibrinolysis: Pathophysiologies of osteonecrosis. Clin Orthop 334:43-56, 1997.
8. Glueck CJ, Glueck HI, Greenfield D, et al: Protein C and S deficiency, thrombophilia, and hypofibrinolysis: Pathophysiologic causes of Legg-Perthes disease. Pediatr Res 35:383-388, 1994.
9. Glueck CJ, Glueck HI, Welch M, et al: Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor. Thromb Haemost 71:195-198, 1994.
10. Glueck CJ, McMahon RE, Bouquot J, et al: Pathophysiology of osteonecrosis of the jaw: Thrombophilia and hypofibrinolysis. Oral Surg Oral Med Oral Pathol 81:557-566, 1996.
11. Gris JC, Schved JF, Brun S, et al: Venous occlusion and chronic cigarette smoking: Dose-dependent decrease in the measurable release of tissue-type plasminogen activator and von Willebrand factor. Atherosclerosis 91:247-255, 1991.
12. Gruppo R, Glueck CJ, McMahon RE, et al: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis Pathophysiology of osteonecrosis of the jaw. J Lab Clin Med 127:481-488, 1996.
13. Jones JP: Intravascular coagulation and osteonecrosis. Clin Orthop 277:41-52, 1992.
14. Kimura S, Nishinaga M, Ozawa T, Shimada K: Thrombin generation as an acute effect of cigarette smoking. Am Heart J 128:7-11, 1994.
15. Matsuo K, Hirohata T, Sugioka Y, Ikeda M, Fukuda A: Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop 234:115-123, 1988.
16. Meijer GG, Postma DS, van der Heide S, et al: Exogenous stimuli and arcadian peak expiratory flow variation in allergic asthmatic children. Am J Respir Crit Care Med 153:237-242, 1996.
17. Norlin R, Hammersby S, Tkaszuk H: The natural history of Perthes disease. Int Orthop 15:13-16, 1991.
18. Osland JD, Schoenecker PL: Association of passive smoking as a primary etiological factor in the pathogenesis of Legg-Perthes disease. Orthop Trans 19:705, 1996. Abstract.
19. Ozdemir O, Karaaslan Y, Ozoebe O, Dundar S, Kirazli S: The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic-smokers. Thromb Res 65:263-274, 1992.
20. Shabib SM, Cutz E, Sherman PM: Passive smoking is a risk factor for esophagitis in children. J Pediatr 127:435-437, 1995.
21. Smith FB, Lee AJ, Rumley A, Fowkes FG, Lowe GD: Tissue-plasminogen activator plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 115:35-43, 1995.
22. Snedecor GW, Cochran WG: Statistical Methods. Ed 7. Ames. IA, Iowa State University Press 1980.
23. Soyseth V, Kongerud J, Boc J: Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 107:389-394. 1995.
24. van Poppel G, Hosper J, Nieuwenhuizen W, Laterveer R: No influence of beta carotene on haemostatic balance in healthy male smokers. Blood Coagul Fibrinolysis 6:55-59, 1995.
25. Zahger D, Cercek B, Cannon CP, et al: How do smokers differ from nonsmokers in their response to thrombolysis? Am J Cardiol 75:232-236, 1995.